Literature DB >> 58213

Letter: Bromocriptine and hypertension.

S B Kaye, K M Shaw, E J Ross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 58213     DOI： 10.1016/s0140-6736(76)91556-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  The effects of bromocriptine in methyldopa treated hypertension.

Authors:  M J Lewis; A H Henderson
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

2.  [Raised plasma-prolactin levels in essential hypertension: index of reduced hypothalamic dopaminergic activity (author's transl)].

Authors:  R Kolloch; K O Stumpe; M Higuchi; H Vetter; F Krück
Journal:  Klin Wochenschr       Date:  1977-10-15

3.  Cause of death among patients with Parkinson's disease: a rare mortality due to cerebral haemorrhage.

Authors:  S Iwasaki; Y Narabayashi; K Hamaguchi; A Iwasaki; M Takakusagi
Journal:  J Neurol       Date:  1990-04       Impact factor: 4.849

4.  Involvement of the adrenal glands in the hypotensive response to bromocriptine in spontaneously hypertensive rats.

Authors:  T C Hamilton
Journal:  Br J Pharmacol       Date:  1981-03       Impact factor: 8.739

5.  Bromocriptine in the treatment of hypertension.

Authors:  R J Walden; J Hernandez; P Bhattacharjee; B Graham; B N Prichard
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Bromocriptine reduces plasma noradrenaline and 3,4-dihydroxyphenylacetic acid in normal and hypotensive subjects.

Authors:  G Mercuro; Z L Rossetti; L Tocco; C A Rivano; A Cherchi; G L Gessa
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  The effect of bromocriptine on plasma catecholamine concentrations in normal volunteers.

Authors:  L Steardo; E Di Stasio; S Bonuso; M Maj
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.